Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07420582

Antegrade Autologous Blood Reinfusion After CPB

The Effect of Antegrade Pump Blood Reinfusion Via Crystalloid "Chase" Technique on Postoperative Transfusion Requirements in Adult Cardiac Surgery Patients: A Prospective Observational Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
130 (estimated)
Sponsor
Kocaeli City Hospital · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This prospective observational study aims to evaluate the effect of antegrade pump blood reinfusion using the crystalloid "chase" technique on postoperative transfusion requirements in adult patients undergoing cardiac surgery with cardiopulmonary bypass. At the end of cardiopulmonary bypass, blood remaining within the cardiopulmonary bypass circuit is reinfused antegradely through the arterial line using a crystalloid chase, without collection or storage. Blood remaining within the bypass circuit after surgery represents a valuable source of autologous blood, and its reinfusion may contribute to perioperative blood conservation strategies. Patients receiving antegrade pump blood reinfusion via the chase technique will be compared with those managed without reinfusion, without any intervention by the investigators. The primary outcome is postoperative blood transfusion requirement.

Conditions

Interventions

TypeNameDescription
PROCEDUREAntegrade Pump Blood ReinfusionAdult patients undergoing cardiac surgery with cardiopulmonary bypass in whom antegrade pump blood reinfusion is performed at the end of bypass using the crystalloid chase technique, as part of routine clinical practice.
OTHERNo Anterograde Pump Blood ReinfusionAdult patients undergoing cardiac surgery with cardiopulmonary bypass in whom anterograde pump blood reinfusion is not performed at the end of bypass. Standard institutional clinical management is applied.

Timeline

Start date
2026-02-23
Primary completion
2026-06-01
Completion
2026-06-15
First posted
2026-02-19
Last updated
2026-02-24

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07420582. Inclusion in this directory is not an endorsement.